Clinical Trial Update: Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases [Phase 3]

View source ↗

Summary

Phase 3 trial investigating early or delayed brain radiotherapy combined with almonertinib in EGFR-mutated non-small cell lung cancer with brain metastases; cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Almonertinib (almonertinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Brain Metastases, Radiotherapy | Phase 3 | Status: RECRUITING